These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10812646)

  • 1. [Further evidence for the renoprotective effect of ACE inhibitors: ramipril protects against the progression of chronic renal insufficiency in non-diabetic nephropathy with nephrotic proteinuria].
    Mayr M; Dickenmann MJ
    Schweiz Med Wochenschr; 2000 Apr; 130(13):491. PubMed ID: 10812646
    [No Abstract]   [Full Text] [Related]  

  • 2. REIN on obesity, proteinuria and CKD.
    Choi ME
    J Am Soc Nephrol; 2011 Jun; 22(6):990-2. PubMed ID: 21617125
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
    Ruggenenti P; Perna A; Gherardi G; Benini R; Remuzzi G
    Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.
    Ruggenenti P; Perna A; Gherardi G; Garini G; Zoccali C; Salvadori M; Scolari F; Schena FP; Remuzzi G
    Lancet; 1999 Jul; 354(9176):359-64. PubMed ID: 10437863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ACE inhibitors--a potential new group of drugs for treatment of kidney diseases].
    Podracká L; Sasinka M; Böör A
    Cesk Pediatr; 1993 Jan; 48(1):29-31. PubMed ID: 8477465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
    Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
    Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE-inhibitors and progression of chronic renal insufficiency: a contribution of Italian clinical research.
    Andreucci VE; Gallieni M; Brancaccio D
    J Nephrol; 1998; 11(3):105-9. PubMed ID: 9650118
    [No Abstract]   [Full Text] [Related]  

  • 10. ACE inhibition is renoprotective among obese patients with proteinuria.
    Mallamaci F; Ruggenenti P; Perna A; Leonardis D; Tripepi R; Tripepi G; Remuzzi G; Zoccali C;
    J Am Soc Nephrol; 2011 Jun; 22(6):1122-8. PubMed ID: 21527660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ACE inhibitors--a prospective new group of drugs for the treatment of kidney diseases].
    Podracká L; Sasinka M; Böör A
    Cesk Pediatr; 1992 Dec; 47(12):730-2. PubMed ID: 1294314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ramipril lowers plasma FGF-23 in patients with diabetic nephropathy.
    Yilmaz MI; Sonmez A; Saglam M; Kurt YG; Unal HU; Karaman M; Gok M; Cetinkaya H; Eyileten T; Oguz Y; Vural A; Mallamaci F; Zoccali C
    Am J Nephrol; 2014; 40(3):208-14. PubMed ID: 25324042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitor for slowing progression of diabetic and nondiabetic kidney disease.
    Myers BD; Boothroyd D; Olshen RA
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S66-70. PubMed ID: 11443771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal protection: progression, regression, remission from nephropathy beyond blood pressure control.
    Remuzzi G
    Int J Clin Pract Suppl; 2000 May; (110):9-15. PubMed ID: 10912302
    [No Abstract]   [Full Text] [Related]  

  • 15. ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy.
    Ruggenenti P; Perna A; Remuzzi G
    J Am Soc Nephrol; 2001 Dec; 12(12):2832-2837. PubMed ID: 11729254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
    Pisoni R; Faraone R; Ruggenent P; Remuzzi G
    J Nephrol; 2002; 15(4):428-30. PubMed ID: 12243375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists].
    Tesar V
    Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How to slow the progression of chronic renal insufficiency].
    Rossert J; Ronco P
    Rev Prat; 2001 Feb; 51(4):378-84. PubMed ID: 11355601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How much must blood pressure be reduced in order to obtain the remission of chronic renal disease?
    Pisoni R; Remuzzi G
    J Nephrol; 2000; 13(3):228-31. PubMed ID: 10928301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and progression of renal disease.
    Maschio G; Oldrizzi L; Marcantoni C; Rugiu C
    J Nephrol; 2000; 13(3):225-7. PubMed ID: 10928300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.